Private Investors would obviously want it BIG TIME to be able to eventually unload some shares on retail.
Since this meeting tomorrow is hosted by Solebury Trout, their IR team, along with BMO & Davis Polk .... hmm ...
Sounds to me like this shindig coupled with what Javitt has to say could be the murmurings (or more) of financing rounds leading to an IPO for NeuroRX.
This would be really good for everybody involved and actually makes a lot of sense, the more I think of NeuroRX as “independent” but also as an essential facet to $RLFTF ... hrrrmmmm!
News 
Market Data 
Discover 
